Antares Pharma Inc. (ATRS) experienced unusually high volume on Apr. 25, as the stock lost 0.98% to a closing price of $1.01. The stock saw 2.68 million shares trade hands over the course of the day on 1,646 trades. …
Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F ... Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes. All …
The stock’s market capitalization is 260.50M, it has a 52-week low of 0.67 and a 52-week high of 1.85. The share price of the company (ATRS) was down -2.89%, with a high of 1.74 during the day and the volume of Antares …
Analysts on the Street predict that Antares Pharma, Inc. (NASDAQ:ATRS) is going to report earnings of $-0.04 ... It’s all about the ABR An investor wants to determine the consensus on a stock, and they can do that by …
On last trading day, Antares Pharma, Inc. (NASDAQ:ATRS) traded 833145 shares and was closed at $2.35 per share. Company stock is -3.29% away from its one year high and is moving 250.75% ahead of its one year …
Two drug makers and two real estate investment trusts unveiled stock offerings after hours. Antares Pharma Inc. ATRS, +3.10% plans to offer an undisclosed number of shares, as it seeks to raise funds to develop its …
Stock
Antares Pharma, Inc. (Nasdaq: ATRS) has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price to the public of $4.00 per share, resulting in net …
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding …
ATRS free research report PDF is just a click away at: Birmingham, Alabama headquartered HEALTHSOUTH …
Healthways
(You may have to copy and paste the links into your browser) ATRS Research Package: http://stock